Heating Block System Marks a Milestone
Asynt has announced that its DrySyn Heating block range is now used by over 1000 establishments worldwide including many leading universities and highly respected companies.
First introduced over 11 years ago and continuously improved since, many scientists worldwide have come to rely on its unique design and safety features for their chemistry experiments. The DrySyn Classic was the first model introduced by Asynt to the chemistry community. Today the DrySyn range additionally includes Scholar, Multi, Maxi and Snowstorm models for heated and cooled reactions.
New engineering techniques have enabled Asynt to develop the latest generation of DrySyn Classic Heating Blocks which deliver faster heating rates and unmatched safety features.
Completely compatible with all previous models, the 2015 DrySyn Classic Heating Block range offers excellent heat transfer performance up to 300°C, faster heating rates and stronger coupling for magnetic stirring — all in a compact footprint. The DrySyn Classic includes as standard heat resistant safety lifting handles to allow fast, easy and safe lifting of your reaction flask from the heater/stirrer. To enhance its versatility, removable and adjustable feet enable the DrySyn Classic to be used with all magnetic stirring hotplates.
Used in combination with a standard hotplate stirrer, DrySyn Classic units are proven to outperform the heat-conducting properties of oil baths. They pose a far lower fire risk and their use makes the clean-up of glassware far easier as there is no residual oil contamination on the outside of the flasks. The DrySyn Classic also provides a superior alternative to heating mantles. In addition to accelerating your chemical reactions - DrySyn Classic heating blocks ensure a safer, cleaner, healthier working environment.
The highly affordable DrySyn Classic system consists of a base that will accommodate 1000-mL flasks and four inserts for 500 mL, 250 mL, 100 mL and 50 mL flasks. Solid anodised aluminium construction delivers outstanding thermal and magnetic transfer efficiency and the durability suitable for use in any laboratory environment.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance